Rafael Holdings, Inc. RFL
0.99 USD +0.07 (+8.07%)
Regular-session close
1.00 +0.01 +1.10%
After hours · Nov 18, 7:44 PM ET
0.8637 Day range 0.9959
0.8637 52-week range 3.96
- YTD
- -16.35%
- 1 year
- -19.75%
News
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Bullfrog AI Hldgs (NASDAQ:BFRG) stock moved upwards by 21.2% to $0.5 during Wednesday's pre-market session. The company's market cap stands at $7.6 million. As per the press release, Q3…
prnewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL NEW YORK, Nov. 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Rafael Holdings, Inc. ("Rafael" or the "Company") (NYSE: RFL). Such investors are advised to…benzinga.com Rafael Holdings Q4 EPS $(0.18) Up From $(0.28) YoY, Sales $244.000K Down From $350.000K YoY Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.18) per share. This is a 35.71 percent increase over losses of $(0.28) per share from the same period last year. The company reported…
benzinga.com Rafael Holdings Files New Drug Application To FDA For Approval Of Remibetadex To Treat Neurovisceral Manifestations Of Niemann-Pick Disease Type C Rafael Holdings, Inc. (NYSE: RFL) today announced that its subsidiary, Cyclo Therapeutics, LLC, has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking…
